Ying Liu is a seasoned SAS programming professional with extensive experience in statistical and clinical programming. Ying served as a Senior Manager of Statistical Programming at Medivation from 2013 to 2017 and held various roles with increasing responsibility at companies such as AbbVie Biotherapeutics Corp. and POINT Biopharma, where Ying was a Senior Director until its acquisition by Eli Lilly and Company in December 2023. Currently, Ying is the Executive Director of Statistical & Clinical Programming at Eli Lilly and Company, showcasing strong leadership and execution skills throughout their career. Ying earned a B.S. from Shanghai University of Science and Technology and an M.S. from the University of Maryland Baltimore County.
This person is not in the org chart
This person is not in any teams
This person is not in any offices